UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer

Cancer Control, 2022-02, Vol.29, p.10732748221078470-10732748221078470

2022

Volltextzugriff (PDF)

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma

Scientific reports, 2019-11, Vol.9 (1), p.17608-11, Article 17608

2019

Volltextzugriff (PDF)

Estrogen Receptor (ER)-β Isoforms: A Key to Understanding ER-β Signaling

Proceedings of the National Academy of Sciences - PNAS, 2006-08, Vol.103 (35), p.13162-13167

2006

Volltextzugriff (PDF)

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

PloS one, 2017-02, Vol.12 (2), p.e0171824-e0171824

2017

Volltextzugriff (PDF)

Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer

Cancer letters, 2019-09, Vol.459, p.41-49

2019

Volltextzugriff (PDF)

Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma

Cancers, 2024-09, Vol.16 (18), p.3175

2024

Volltextzugriff (PDF)

Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers-Improvements in Clinical Efficacy and Safety

Biomedicines, 2023-07, Vol.11 (7), p.2000

2023

Volltextzugriff (PDF)

Surgical stress delays prostate involution in mice

PloS one, 2013-11, Vol.8 (11), p.e78175-e78175

2013

Volltextzugriff (PDF)

BAD dephosphorylation and decreased expression of MCL-1 induce rapid apoptosis in prostate cancer cells

PloS one, 2013-09, Vol.8 (9), p.e74561

2013

Volltextzugriff (PDF)

Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer

Neoplasia (New York, N.Y.), 2013-10, Vol.15 (10), p.1172-IN32

2013

Volltextzugriff (PDF)

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer

Frontiers in pharmacology, 2021-09, Vol.12, p.746385-746385

2021

Volltextzugriff (PDF)

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma

Translational oncology, 2018-04, Vol.11 (2), p.426-435

2018

Volltextzugriff (PDF)

Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times

PloS one, 2022-11, Vol.17 (11), p.e0276492

2022

Volltextzugriff (PDF)

Behavioral stress accelerates prostate cancer development in mice

The Journal of clinical investigation, 2013-02, Vol.123 (2), p.874-874

2013

Volltextzugriff (PDF)

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells

The Prostate, 2023-02, Vol.83 (3), p.237-245

2023

Volltextzugriff (PDF)

Abstract 2208: Targeted inhibition of FGF/PDGF/VEGF signaling enhances nanoparticle taxane response in preclinical gastric cancer models

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2208-2208

2019

Volltextzugriff (PDF)

Abstract 5939: Enhancing nab-paclitaxel chemotherapy response in gastric cancer preclinical models through Inhibition of the HGF/c-Met pathway with merestinib

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5939-5939

2024

Volltextzugriff (PDF)

Protein Kinase D1 Suppresses Epithelial-to-Mesenchymal Transition through Phosphorylation of Snail

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (20), p.7810-7819

2010

Volltextzugriff (PDF)

Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models

Cancer biology & therapy, 2021-12, Vol.22 (10-12), p.619-629

2021

Volltextzugriff (PDF)

Polyphenolic antioxidants mimic the effects of 1,4-dihydropyridines on neurotensin receptor function in PC3 cells

The Journal of pharmacology and experimental therapeutics, 2004-04, Vol.309 (1), p.92-101

2004

Volltextzugriff (PDF)

Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models

Journal of cellular and molecular medicine, 2021-06, Vol.25 (11), p.4950-4961

2021

Volltextzugriff (PDF)

Abstract 5807: The dual c-Met/VEGFR2 inhibitor foretinib augments chemotherapy response in preclinical models of gastric cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5807-5807

2018

Volltextzugriff (PDF)

β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

Molecular cancer research, 2020-12, Vol.18 (12), p.1839-1848

2020

Volltextzugriff (PDF)

Abstract 1258: Therapeutic potential of the cyclin- dependent kinase inhibitor on c-Myc overexpressing esophageal adenocarcinoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1258-1258

2016

Volltextzugriff (PDF)

Abstract 2624: Methadone hydrochloride blocks epinephrine-induced proliferation and enhances apoptotic effects of nab-paclitaxel in esophageal adenocarcinoma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2624-2624

2022

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma

Estrogen Receptor (ER)-β Isoforms: A Key to Understanding ER-β Signaling

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer

Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma

Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers-Improvements in Clinical Efficacy and Safety

Surgical stress delays prostate involution in mice

BAD dephosphorylation and decreased expression of MCL-1 induce rapid apoptosis in prostate cancer cells

Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma

Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times

Behavioral stress accelerates prostate cancer development in mice

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells

Abstract 2208: Targeted inhibition of FGF/PDGF/VEGF signaling enhances nanoparticle taxane response in preclinical gastric cancer models

Abstract 5939: Enhancing nab-paclitaxel chemotherapy response in gastric cancer preclinical models through Inhibition of the HGF/c-Met pathway with merestinib

Protein Kinase D1 Suppresses Epithelial-to-Mesenchymal Transition through Phosphorylation of Snail

Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models

Polyphenolic antioxidants mimic the effects of 1,4-dihydropyridines on neurotensin receptor function in PC3 cells

Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models

Abstract 5807: The dual c-Met/VEGFR2 inhibitor foretinib augments chemotherapy response in preclinical models of gastric cancer

β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1

Abstract 1258: Therapeutic potential of the cyclin- dependent kinase inhibitor on c-Myc overexpressing esophageal adenocarcinoma

Abstract 2624: Methadone hydrochloride blocks epinephrine-induced proliferation and enhances apoptotic effects of nab-paclitaxel in esophageal adenocarcinoma

Suchergebnisse filtern